Logo for Livzon Pharmaceutical Group Inc

Livzon Pharmaceutical Group Inc Investor Relations Material

Latest events

Logo for Livzon Pharmaceutical Group Inc

Q1 2024

23 Apr, 2024
Logo for Livzon Pharmaceutical Group Inc

Q4 2023

28 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Livzon Pharmaceutical Group Inc

Access all reports
Livzon Pharmaceutical Group Inc. is active in the pharmaceutical sector, specializing in the development, manufacturing, and distribution of pharmaceutical products. The company's product portfolio includes preparation drug products, bulk medicines and intermediates, diagnostic reagents, and equipment. Among its offerings, Livzon provides treatments for a range of therapeutic areas such as antibiotics, antibacterial, gastrointestinal, psychotropic, antiviral, immunomodulation, anti-allergic, and traditional Chinese medicine. Notable products include menotropin injections, urofollitropin injections, perospirone hydrochloride tablets, and ranitidine bismuth citrate tablets, along with diagnostic kits for various medical conditions. The company is headquartered in Zhuhai, China, and its shares are listed on the Shenzhen Stock Exchange and the Hong Kong Stock Exchange.